At The Uromigos Live & Unplugged event, Katy Beckermann, MD, PhD, Vanderbilt University, shares how she has enjoyed the discussion on belzutifan for patients with kidney cancer, and why there is a need to identify a biomarker for patients who will benefit from this drug.
The enthusiasm and pointed questions of the Uromigos Cup events have stood out to her at this year’s event.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.